Better Info on H1N1: Cidrap at U. Minnesota
Here is a compendium of very useful info on H1N1, both for clinicians and the public. It appears to be regularly updated. Cidrap has gathered its information from WHO, CDC and other sources.
Albanians celebrate on a monument to the national hero Skanderbeg after Edi Rama rejected the US request to host the chemical weapons. Photo: Arben Celi/Reuters The UN’s Organization for the Prohibition of Chemical Weapons (OPCW) has completed its inspection work in Syria on time, and without any major hitch. All production facilities for chemical weapons have…
NYC Education Department expects to lose 5,500 workers, according to today’s NY Post. They are seeking subs. The Washington Post tells us that nationwide, only 60% of police, firemen and EMS first responders are vaccinated. No one knows how many military servicemembers are saying no, but it is a lot. These folks, like me, do…
Dr. Annette Hanson penned the following piece on the ethically impaired “Expert Behavioral Analysis Panel” paid for by FBI: In March, a panel chaired by Dr. Gregory Saathoff, commonly known as the expert behavioral analysis panel (EBAP), released a report containing a summary and analysis of the investigation of Dr. Bruce Ivins, the suspected anthrax…
Helen Branswell reports on “a bold proposal on how to circumvent too-slow production and too-little output of influenza vaccine during a pandemic.” You saw it here and here first, when I blogged about what pandemic “experts” talk about when they don’t have a pandemic: so-called “pre-pandemic” vaccinations. It would be a great idea if we…
UPDATE: I was reminded that a fellow named Raymond Davis, a CIA contractor (formerly of Blackwater/Xe) shot two Pakistanis on motorcyces to death in February. President Obama claimed he was “our diplomat”and insisted Pakistan grant him immunity under the Vienna Convention on diplomatic immunity of 1961. Davis had a car full of weapons, disguises and…
French physician and pharmacoepidemiologist Marc Girard has written a valuable piece on swine flu vaccines, their risk assessment and their rushed approval, contrasting this with what should ordinarily take place before a drug or vaccine enters the market.